Literature DB >> 18024368

Bortezomib-induced peripheral neurotoxicity: still far from a painless gain.

Guido Cavaletti, Eduardo Nobile-Orazio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18024368     DOI： 10.3324/haematol.11752

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

Review 1.  Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.

Authors:  Gerardo Gutiérrez-Gutiérrez; María Sereno; Ambrosio Miralles; Enrique Casado-Sáenz; Eduardo Gutiérrez-Rivas
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

2.  Chemotherapy-induced neuropathy.

Authors:  Guido Cavaletti; Paola Alberti; Barbara Frigeni; Marialuisa Piatti; Emanuela Susani
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

Review 3.  Chemotherapy-induced peripheral neurotoxicity.

Authors:  Guido Cavaletti; Paola Marmiroli
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

4.  Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma.

Authors:  Claudio Cartoni; Gregorio Antonio Brunetti; Vincenzo Federico; Fabio Efficace; Sara Grammatico; Andrea Tendas; Laura Scaramucci; Luca Cupelli; Gianna Maria D'Elia; Andrea Truini; Pasquale Niscola; Maria Teresa Petrucci
Journal:  Support Care Cancer       Date:  2012-06-15       Impact factor: 3.603

Review 5.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

Review 6.  Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia.

Authors:  Jacob P Laubach; Constantine S Mitsiades; Aldo M Roccaro; Irene M Ghobrial; Kenneth C Anderson; Paul G Richardson
Journal:  Leuk Lymphoma       Date:  2009-05

7.  Bortezomib in the management of multiple myeloma.

Authors:  Jacob P Laubach; Constantine S Mitsiades; Teru Hideshima; Robert Schlossman; Dharminder Chauhan; Nikhil Munshi; Irene Ghobrial; Nicole Carreau; Kenneth C Anderson; Paul G Richardson
Journal:  Cancer Manag Res       Date:  2009-09-08       Impact factor: 3.989

8.  CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.

Authors:  Cristina Meregalli; Cecilia Ceresa; Annalisa Canta; Valentina Alda Carozzi; Alessia Chiorazzi; Barbara Sala; Norberto Oggioni; Marco Lanza; Ornella Letari; Flora Ferrari; Federica Avezza; Paola Marmiroli; Gianfranco Caselli; Guido Cavaletti
Journal:  J Pain Res       Date:  2012-06-20       Impact factor: 3.133

9.  Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse.

Authors:  Valentina A Carozzi; Cynthia L Renn; Michela Bardini; Grazia Fazio; Alessia Chiorazzi; Cristina Meregalli; Norberto Oggioni; Kathleen Shanks; Marina Quartu; Maria Pina Serra; Barbara Sala; Guido Cavaletti; Susan G Dorsey
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

10.  Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?

Authors:  Sven Schröder; Kathrin Beckmann; Giovanna Franconi; Gesa Meyer-Hamme; Thomas Friedemann; Henry Johannes Greten; Matthias Rostock; Thomas Efferth
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.